Responses
Abstract
Free Communications
RELATIONSHIP OF TIME TO RELAPSE (TTR) AND SURVIVAL POST RELAPSE (SPR): EXPLORATION OF RISK FACTORS FROM THE FOLLOW-UP DATASET OF A RANDOMIZED PBO-CONTROLLED STUDY OF OREGOVOMAB (OV) AS A CONSOLIDATION THERAPY FOR PATIENTS WITH ADVANCED OVARIAN CANCER (OC)
Compose a Response to This Article
Other responses
No responses have been published for this article.